245 Remission/low disease activity is an achievable treatment target in psoriatic arthritis (PsA): results from a routine care European cohort of PsA patients treated with ustekinumab or TNF inhibitors. (12th April 2019) - Siebert, Stefan; Gossec, Laure; Bergmans, Paul; de Vlam, Kurt; Gremese, Elisa; Joven, Beatriz E; Korotaeva, Tatiana; Wright, Pamela B; Kent, Toby; Noel, Wim; Nurmohamed, Michael; Sfikakis, Petros; et al.